Small cell lung cancer (SCLC) is a less common type of lung cancer, found in approximately 13% of all lung cancer patients. GO2 for Lung Cancer is prioritizing this vulnerable, historically underserved patient community through improved access to cutting-edge research and meaningful support. Learn more about our small cell lung cancer initiative and read their stories.
